PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that it has acquired Dexela Limited, a London, UK-based provider of flat panel Complementary Metal-Oxide-Semiconductor (CMOS) X-ray detection technologies and services.
“Dexela has been a pioneer in the development of CMOS X-ray detection solutions and has achieved award-winning recognition in the imaging market for its design strengths and ease of manufacturability - which are major advantages for OEM customers”
The acquisition of Dexela expands PerkinElmer's current medical imaging portfolio in key areas including surgery, dental CT, cardiology, and mammography, as well as non-destructive testing (NDT). With the addition of the CMOS technology to the Company's imaging portfolio, customers will now be able to choose seamlessly between two complementary X-ray detector technologies to optimize their system performance and meet their specific application needs.
Founded in 2005, Dexela develops and commercializes its CMOS technology portfolio, which includes hardware and software offerings for fast, low-dose X-ray imaging. The company's CMOS products offer high spatial resolution, frame rate and reliability, low noise and absence of image lag. The Dexela technology is designed to provide high image quality, whether detecting defects in human tissue or industrial objects and structures, through design-friendly components that can be easily incorporated into an Original Equipment Manufacturer (OEM) instrument or platform.
In addition to its CMOS X-ray detection units, Dexela technologies and services include its Dexela Mammography Workstation, the DexView Image Processing Software, its 3D Reconstruction Engine Software, and Consulting and Implementation Services
"Dexela has been a pioneer in the development of CMOS X-ray detection solutions and has achieved award-winning recognition in the imaging market for its design strengths and ease of manufacturability - which are major advantages for OEM customers," said Brian Giambattista, President, Medical Imaging, PerkinElmer. "We look forward to expanding the reach of this promising technology into adjacent markets such as surgery, dental CT, cardiology, mammography and industrial NDT, to detect, monitor and remediate threats to human health or structural integrity."
SOURCE PerkinElmer, Inc.